Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Thyas
company
About
Thyas provides preparations of regenerative immunocell therapy for cancer and infection.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥240M
- Industries
- Health Care,Medical,Therapeutics
- Founded date
- Aug 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Thyas Co. Ltd. provides preparations of regenerative immunocell therapy for cancer and infection.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥240M
Thyas has raised a total of
¥240M
in funding over 2 rounds. Their latest funding was raised on
Nov 20, 2019 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 20, 2019 | Series Unknown | ¥240M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Thyas is funded by 1 investors.
Chuo Shinkin Venture Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
